05/12/2016 07:00:33

Metso head office has moved to new premises

Related content
14 Dec - 
Metso's Board of Directors decides on long-term incenti..
21 Nov - 
Metso Corporation: Managers' transactions - Nico Delvau..
15 Nov - 
Notification according to chapter 9, section 5 and 6 of..

Metso head office has moved to new premises 

Metso Corporation's stock exchange release on December 5, 2016 at 9:00 a.m. EET

  

Metso's head office has moved to new premises as of December 5, 2016. The new visiting address of the head office is:

   

Metso Corporation

Töölönlahdenkatu 2

FIN-00100 Helsinki

  

Our mailing address and telephone numbers will remain the same. 

   

Head office mailing address:

   

Metso Corporation

PO Box 1220

FI-00101 Helsinki, Finland

  

The telephone switchboard number: +358 20 484 100

  

Metso is a world leading industrial company serving the mining, aggregates, recycling, oil, gas, pulp, paper and process industries. We help our customers improve their operational efficiency, reduce risks and increase profitability by using our unique knowledge, experienced people and innovative solutions to build new, sustainable ways of growing together.

Our products range from mining and aggregates processing equipment and systems to industrial valves and controls. Our customers are supported by a broad scope of services and a global network of over 80 service centers and about 6,400 services professionals. Metso has an uncompromising attitude towards safety.

Metso is listed on the NASDAQ OMX Helsinki, Finland, and had net sales of about EUR 2.9 billion in 2015. Metso employs over 12,000 persons in more than 50 countries. Expect results.

www.metso.com

,

twitter.com/metsogroup

F

urther information, please contact:

Helena Marjaranta, Vice President, Global Communications, Metso Corporation, tel. +358 20 484 3212, Email: helena.marjaranta@metso.com

    

Eeva Sipilä

CFO

  

Juha Rouhiainen

VP, Investor Relations

  

Distribution:

NASDAQ OMX Helsinki Ltd

Media

www.metso.com


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Metso Corporation via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Form 8.3 - Tesco PLC

14/12/2017 11:47:54
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Jupiter Asset Management (b) Owner or controlle..

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

14/12/2017 10:47:13
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Alliance Trust PLC : Transaction in Own Shares

14/12/2017 07:00:14
14 December 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 13 December 2017 the Company purchased for cancellation 100,000 ordinary shares of 2.5p each at a price of 739.7112p per share.  Therefore, the total number of voting rights in the Company is now 347,776,156.    The above figure (347,776,156) may be used by sha..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Voip-Pal.com, Inc. Discusses the Global Potential of its RBR Parent Patent
2
Make Christmas Personal with New Celebrity Video Ecards from American Greetings
3
Impac Mortgage Holdings, Inc. Announces Hire of Rian Furey to lead its Consumer Direct Retail Channel
4
Kirkland Lake Gold Provides Final Reminder of December 15, 2017 Conversion Deadline to Convertible Debenture Holders
5
Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

Related stock quotes

Metso Corporation 29.86 -1.3% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
15 December 2017 08:07:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171124.1 - EUROWEB4 - 2017-12-15 09:07:27 - 2017-12-15 08:07:27 - 1000 - Website: OKAY